Publication | Open Access
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment
35
Citations
28
References
2014
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1